Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Myriad Genetics Inc.
About MYGN
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health, and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test, which can reveal a baby's gender as early as six weeks into pregnancy. The Company’s testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, Foresight, Prequel, Precis Tumor, Precise Liquid, SneakPeek and GeneSight, among others.
Find out what a historical investment in Myriad Genetics Inc. would be worth today using our MYGN stock calculator.
Market Capitalisation
$335.29M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.1M
High today
$3.82
Low today
$3.54
Open price
$3.55
52-week high
$8.59
52-week low
$3.53
Ready to start your investing journey with Stake?
Open an accountHow do I buy MYGN shares in Australia?
Buying MYGN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Myriad Genetics Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MYGN
What is the ticker symbol of Myriad Genetics Inc.?
The ticker symbol for Myriad Genetics Inc. is MYGN.
How much is one share of MYGN?
One share of MYGN is valued at $3.78 as of 20 May 2026.
What is the market capitalisation of Myriad Genetics Inc. MYGN?
As of 20 May 2026 Myriad Genetics Inc. has a market cap of $335.29M.
What is the 52-week high for Myriad Genetics Inc. stock?
The Myriad Genetics Inc. 52-week high stock price is $8.59.
What is the 52-week low for Myriad Genetics Inc. stock?
The Myriad Genetics Inc. 52-week low stock price is $3.53.
Can I buy MYGN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MYGN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MYGN on Stake
- Buy MYGN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of MYGN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
MYGN related stocks